Current Report Filing (8-k)
October 22 2018 - 5:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
October
15, 2018
CRYO CELL International, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
|
|
Delaware
|
|
000-23386
|
|
22-3023093
|
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File No.)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
700 Brooker Creek Boulevard, Oldsmar, Florida
|
|
34677
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code: (813)
749-2100
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17
CFR
240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange
Act). Yes ☐ No ☒
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
On October 15, 2018, Cryo-Cell International, Inc. (the “Registrant”) issued the attached Press Release reporting on financial
results for the three months ended August 31, 2018. The press release giving details associated with the Registrant’s earnings is attached as Exhibit 99.1 to this report. The information included in Exhibit 99.1 is considered to be
“furnished” under the Securities Exchange Act of 1934.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
|
|
|
|
|
|
Financial Statements of Businesses Acquired.
|
|
Not Applicable.
|
|
|
|
|
|
|
|
Pro Forma Financial Information
|
|
Not Applicable.
|
|
|
|
|
|
|
|
Shell Company Transactions
|
|
Not Applicable.
|
|
|
Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CRYO CELL International, Inc.
|
|
|
|
|
|
|
DATE: October 22, 2018
|
|
|
|
By:
|
|
/s/ David Portnoy
|
|
|
|
|
|
|
|
|
|
David Portnoy
Chairman,
Co-CEO
|